Published in J Clin Microbiol on April 14, 2010
Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob Agents Chemother (2011) 0.97
Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (2011) 0.75
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol (2000) 34.08
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (1997) 18.24
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science (2003) 7.73
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 7.52
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol (2004) 6.65
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A (2007) 6.14
First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet (1998) 4.08
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis (2004) 4.06
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis (2008) 3.95
Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep (2002) 3.95
Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol (2003) 3.89
The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis (2007) 3.52
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis (2003) 3.39
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol (2006) 3.34
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother (2003) 2.80
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol (2006) 2.74
The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med (1998) 2.58
Infective endocarditis. Clin Infect Dis (1993) 2.52
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother (2005) 2.34
Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin. J Bacteriol (2006) 2.32
Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet (1999) 2.30
Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol (2000) 2.16
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J Clin Microbiol (2008) 2.07
National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis (2007) 1.96
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother (2008) 1.89
Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol (2005) 1.88
Rapid detection of the pandemic methicillin-resistant Staphylococcus aureus clone ST 239, a dominant strain in Asian hospitals. J Clin Microbiol (2008) 1.87
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis (2004) 1.84
MRSA--the tip of the iceberg. Clin Microbiol Infect (2006) 1.81
Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis (2004) 1.73
Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect (2003) 1.72
First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol (2001) 1.69
Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J Clin Microbiol (1999) 1.68
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother (2006) 1.66
tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.64
Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J Hosp Infect (2007) 1.57
Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis (2005) 1.53
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 1.48
Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers. BMC Genomics (2006) 1.45
Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents (2000) 1.43
A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus. BMC Genomics (2005) 1.41
Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Antimicrob Agents Chemother (2008) 1.37
Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother (2004) 1.34
A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother (2005) 1.33
Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis (2008) 1.21
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother (2002) 1.18
Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. Am J Med (1986) 1.15
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15
Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol Direct (2009) 1.07
Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998. J Clin Microbiol (2005) 1.07
Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.05
Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance. Antimicrob Agents Chemother (2003) 1.04
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrob Agents Chemother (2009) 1.03
Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J Clin Microbiol (2001) 0.99
In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother (2001) 0.99
Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob (2006) 0.98
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization. Diagn Microbiol Infect Dis (2003) 0.85
Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from major hospitals in Riyadh, Saudi Arabia. Can J Microbiol (2007) 0.82
Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and wales. J Antimicrob Chemother (2000) 0.80
Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals. Clin Microbiol Infect (2005) 0.79
Use of antibiotics in the poultry industry in Saudi Arabia: implications for public health. Ann Saudi Med (2007) 0.76
[Staphylococcus aureus septicemia in children: bacterial tolerance to vancomycin and serum bactericidal activity]. Rev Assoc Med Bras (1995) 0.76
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65
Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med (2000) 2.06
Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun (2001) 1.89
A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease. J Exp Med (1999) 1.87
Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85
Hydrothermal recharge and discharge across 50 km guided by seamounts on a young ridge flank. Nature (2003) 1.79
Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol (2001) 1.56
[Agreement between clinical practice guidelines for management of community-acquired pneumonia. A retrospective study of 101 hospitalized patients]. Rev Mal Respir (2003) 1.39
Localized thrombotic purpura: a rare complication of chickenpox. J Pediatr (1997) 1.38
Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect (2012) 1.37
Application and use of various mass spectrometry methods in clinical microbiology. Clin Microbiol Infect (2010) 1.34
Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer (1995) 1.22
Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect (2006) 1.21
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples. Sex Transm Infect (2009) 1.15
Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol (1996) 1.12
Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection. Eur J Clin Microbiol Infect Dis (2009) 1.10
Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect (2010) 1.06
Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin Microbiol Infect (2011) 1.05
Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology (2006) 1.04
Fatal acute melioidosis in a tourist returning from Martinique Island, November 2010. Euro Surveill (2011) 1.04
Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly (2009) 1.03
Highly supralinear feedback inhibition of Ca2+ uptake by the Ca2+ load of intracellular stores. J Biol Chem (1996) 1.02
Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr (1994) 1.00
[Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France]. J Fr Ophtalmol (1991) 0.99
Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis (2010) 0.98
Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays. Infection (2008) 0.98
Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect (2011) 0.98
Community-associated methicillin-resistant Staphylococcus aureus: risk factors for infection, and long-term follow-up. Clin Microbiol Infect (2009) 0.95
Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. Eur J Clin Microbiol Infect Dis (2013) 0.95
Nosocomial malaria from contamination of a multidose heparin container with blood. Infect Control Hosp Epidemiol (2000) 0.95
Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer (1989) 0.95
Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin Microbiol Infect (2011) 0.93
Intracranial ependymoma associated with multiple endocrine neoplasia type 1. J Endocrinol Invest (2010) 0.92
Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect (2013) 0.91
High-throughput typing of Staphylococcus aureus by amplified fragment length polymorphism (AFLP) or multi-locus variable number of tandem repeat analysis (MLVA) reveals consistent strain relatedness. Eur J Clin Microbiol Infect Dis (2008) 0.91
Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer (1989) 0.91
Molecular epidemiology of the nasal colonization by methicillin-susceptible Staphylococcus aureus in Swiss children. Clin Microbiol Infect (2010) 0.90
[Expulsive hemorrhage. Apropos of 6 cases]. Bull Soc Ophtalmol Fr (1968) 0.89
Outpatient satisfaction: validation of a French-language questionnaire: data quality and identification of associated factors. Clin Perform Qual Health Care (2000) 0.89
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 0.88
Monitoring rotavirus environmental contamination in a pediatric unit using polymerase chain reaction. Infect Control Hosp Epidemiol (1999) 0.88
[A familial case of eyelip ptosis with blepharophimosis and epicanthus inversus]. J Genet Hum (1974) 0.88
Strategies for graphical threshold determination. Comput Methods Programs Biomed (1991) 0.88
Appropriateness of blood culture testing parameters in routine practice. Results from a cross-sectional study. Eur J Clin Microbiol Infect Dis (2010) 0.88
Influence of surface treatments developed for oral implants on the physical and biological properties of titanium. (I) Surface characterization. Clin Oral Implants Res (1997) 0.86
[Three cases of pachydermoperiostosis]. J Med Lyon (1972) 0.86
Polymerase-chain reaction/electrospray ionization-mass spectrometry for the detection of bacteria and fungi in bronchoalveolar lavage fluids: a prospective observational study. Clin Microbiol Infect (2014) 0.86
Prospective study of telephone calls to a hotline for infectious disease consultation: analysis of 7,863 solicited consultations over a 1-year period. Eur J Clin Microbiol Infect Dis (2010) 0.85
Formulas for threshold computations. Comput Biomed Res (1991) 0.85
Prospective assessment of fluoroquinolone use in a teaching hospital. Eur J Clin Microbiol Infect Dis (2006) 0.85
[Malignant intraocular non-Hodgkin's lymphoma]. J Fr Ophtalmol (1988) 0.85
Proton channels, plasma membrane potential, and respiratory burst in human neutrophils. Eur J Haematol (1993) 0.84
Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. J Hosp Infect (2011) 0.84
Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clin Microbiol Infect Dis (2011) 0.84
[Tuberculous anal fistulas. 13 cases]. Ann Gastroenterol Hepatol (Paris) (1994) 0.83
[Assay of lactic acid in the cerebrospinal fluid for the diagnosis of bacterial meningitis. Strategies for the choice of discriminatory threshold]. Presse Med (1997) 0.83
Haemocompatibility evaluation of DLC- and SiC-coated surfaces. Eur Cell Mater (2003) 0.82
Posttraumatic ankle arthritis due to a novel Nocardia species. Infection (2010) 0.82
[High incidence of sporadic non-A, non-B hepatitis in Morocco: epidemiologic study]. Bull Soc Pathol Exot (1991) 0.82
Paradoxes of French accreditation. Qual Saf Health Care (2005) 0.81
[ESBL and carbapenemases in Enterobacteriaceae]. Rev Med Suisse (2014) 0.81
[Statistical process control applied to intensity modulated radiotherapy pretreatment controls with portal dosimetry]. Cancer Radiother (2010) 0.81
[Evaluation of inpatient satisfaction. Comparison of different survey methods]. Presse Med (2000) 0.81
[Homocystinuria (3 cases)]. Arch Fr Pediatr (1968) 0.81
Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: a multicenter cross-sectional study. Med Mal Infect (2013) 0.80
[Evaluating the quality of the anesthetic records]. Ann Fr Anesth Reanim (1999) 0.80
Irradiated neuroblastoma in childhood as potential risk factor for subsequent thyroid tumour. Lancet (1988) 0.80
Long-term effects in skin and thyroid after radiotherapy for skin angiomas: a French retrospective cohort study. Eur J Cancer (1991) 0.80
[Thyroid tuberculosis]. Ann Otolaryngol Chir Cervicofac (2005) 0.80
The use of porcine liver (2----3)-alpha-sialyltransferase in the large-scale synthesis of alpha-Neup5Ac-(2----3)-beta-D-Galp-(1----3)-D-GlcpNAc, the epitope of the tumor-associated carbohydrate antigen CA 50. Carbohydr Res (1992) 0.80
Analysis of results in the treatment of peripheral retinoschisis in sex-linked congenital retinoschisis. Graefes Arch Clin Exp Ophthalmol (1989) 0.80
[Evaluation of patient satisfaction in health facilities. Review of the literature]. Rev Epidemiol Sante Publique (1999) 0.80
[Pediatric osteo-articular infections with negative culture results: what about Kingella kingae?]. Rev Med Suisse (2009) 0.80
Severe Mycoplasma hominis infections in two renal transplant patients. Eur J Clin Microbiol Infect Dis (2004) 0.80
[Epidermoid cyst of the fourth ventricle]. J Radiol (2009) 0.79
[Surgical treatment of congenital glaucoma. Long-term results]. J Fr Ophtalmol (1991) 0.79
Pathogenesis, prevention, and therapy of staphylococcal prosthetic infections. Curr Clin Top Infect Dis (2001) 0.79
Effects of amoxicillin treatment on the salivary microbiota in children with acute otitis media. Clin Microbiol Infect (2013) 0.79
Anterior fossa schwannoma mimicking an olfactory groove meningioma: case report and literature review. Neurochirurgie (2013) 0.79
[Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland]. Rev Med Suisse (2012) 0.79
[Evaluation and implementation of in vivo transit dosimetry with an electronic portal imaging device]. Cancer Radiother (2013) 0.78
[Secondary tuberculous infection of a pilonidal sinus]. Ann Gastroenterol Hepatol (Paris) (1991) 0.78
[Ileocecal tuberculosis. Apropos of 27 cases]. Ann Gastroenterol Hepatol (Paris) (1995) 0.78
Immuno-detection of Staphylococcus aureus biofilm on a cochlear implant. Infection (2009) 0.78
[Adequacy of antibiotic therapy to guidelines for urinary tract infection in hospital]. Med Mal Infect (2006) 0.78
[Tuberculosis of the transverse colon. Apropos of 2 cases]. Ann Gastroenterol Hepatol (Paris) (1992) 0.78
Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study. Radiother Oncol (1995) 0.78